India's Aurobindo Pharma jumps after Citi says penicillin-G import price floor removes uncertainty

Aurobindo Pharma

30/01/2026 04:50

** Shares of India's Aurobindo Pharma ARBN.NS jump 4.28% to 1200.10 rupees

** Citi ("sell", PT: 1010 rupees) says India's minimum import price on penicillin-G removes uncertainty, lifting pricing visibility for domestic producers - note

** Brokerage adds the move could help improve utilisation at Aurobindo's penicillin-G plant which has been underutilized due to Chinese competition

** Trading volumes at 3.09 mln shares vs 30-day average of 800,425 shares

** Stock rated "buy" on avg by 25 analysts, median PT at 1337.50 rupees -- data compiled on LSEG

** ARBN dropped 11.35 in 2025, stock down ~2.7% in Jan

 (Reporting by Surbhi Misra in Bengaluru)

 ((Surbhi.Misra@thomsonreuters.com |  X: https://twitter.com/SurbhiMisra_  |;))